Finance

Beta
Lists
CNTX:NASDAQ
Context Therapeutics Inc
$0.59
-8.87%
(-0.058) 1D
Jun 24, 2:14:39 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTX...
Open
$0.67
High
$0.67
Low
$0.58
Mkt. cap
55.56M
Avg. vol.
2.02M
Volume
2.92M
52-wk high
$3.62
52-wk low
$0.58
EPS
-$0.42
Beta
1.61
Shares outstanding
91.88M
No. of employees
15
Open
$0.67
High
$0.67
Low
$0.58
Mkt. cap
55.56M
Avg. vol.
2.02M
Volume
2.92M
52-wk high
$3.62
52-wk low
$0.58
EPS
-$0.42
Beta
1.61
Shares outstanding
91.88M
No. of employees
15
News stories
From sources across the web
About Context Therapeutics Inc
CEO-
Employees15
Founded2015
HeadquartersPhiladelphia, Pennsylvania, United States
SectorPharmaceutical industry
Websitecontexttherapeutics.com
Analyst Ratings
Based on 7 analysts giving stock ratings to CNTX in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CNTX in the last 3 months.
Highest
Current $0.59
$7.00 (+1,078.65%)
Average
$5.67 (+854.71%)
Lowest
$4.00 (+573.51%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$4.00
+573.5%
06/16/2026
Boris Peaker
JonesTrading
Buy
Reiterated
$7.00
+1,078.6%
06/15/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
06/15/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$6.00
+910.3%
06/15/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$5.00
+741.9%
06/15/2026
Biren Amin
Piper Sandler
Buy
Maintained
$7.00
+1,078.6%
06/02/2026
Paul Jeng
Guggenheim
Buy
Maintained
$5.00
+741.9%
05/06/2026
Soumit Roy
JonesTrading
Buy
Maintained
$7.00
+1,078.6%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.83M
8.72M
11.84M
7.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93M
1.89M
1.96M
2.33M
Operating expense
9.76M
10.61M
13.80M
9.34M
Total operating expenses
9.76M
10.61M
13.80M
9.34M
Operating income
-9.76M
-10.61M
-13.80M
-9.34M
Other non operating income
27.08K
83.47K
96.56K
-
EBT including unusual items
-8.83M
-9.69M
-13.03M
-8.68M
EBT excluding unusual items
-8.83M
-9.69M
-13.03M
-8.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.83M
-9.69M
-13.03M
-8.68M
Net profit margin
-
-
-
-
Earnings per share
-0.09
-0.10
-0.14
-0.09
Interest and investment income
903.77K
833.77K
682.48K
520.14K
Interest expense
-
-
-
-
Net interest expenses
903.77K
833.77K
682.48K
520.14K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.75M
-10.61M
-13.80M
-9.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer